![Catherine THIEBLEMONT | Hôpital Saint-Louis (Hôpitaux Universitaires Saint-Louis, Laboisière, Fernand-Widal), Paris | Service d'hémato-oncologie Catherine THIEBLEMONT | Hôpital Saint-Louis (Hôpitaux Universitaires Saint-Louis, Laboisière, Fernand-Widal), Paris | Service d'hémato-oncologie](https://i1.rgstatic.net/ii/profile.image/949746592149508-1603448641817_Q512/Catherine-Thieblemont-2.jpg)
Catherine THIEBLEMONT | Hôpital Saint-Louis (Hôpitaux Universitaires Saint-Louis, Laboisière, Fernand-Widal), Paris | Service d'hémato-oncologie
![PDF) Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas PDF) Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas](https://i1.rgstatic.net/publication/284711309_Combinatorial_targeting_of_nuclear_export_and_translation_of_RNA_inhibits_aggressive_B-cell_lymphomas/links/565c9c5108ae1ef92981ee6e/largepreview.png)
PDF) Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas
![PDF) Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas PDF) Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas](https://i1.rgstatic.net/publication/51052731_Inhibition_of_Anaplastic_Lymphoma_Kinase_ALK_Activity_Provides_a_Therapeutic_Approach_for_CLTC-ALK-Positive_Human_Diffuse_Large_B_Cell_Lymphomas/links/0deec51e95a707cda0000000/largepreview.png)